175 related articles for article (PubMed ID: 34988055)
21. EQ-5D-3L Norms for the European Older Population: Country-Specific Norms for 15 European Countires Based on the Survey of Health, Ageing, and Retirement in Europe.
Buchholz I; Janssen MF
Value Health; 2023 May; 26(5):721-732. PubMed ID: 36396535
[TBL] [Abstract][Full Text] [Related]
22. Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies.
Zrubka Z; Golicki D; Prevolnik-Rupel V; Baji P; Rencz F; Brodszky V; Gulácsi L; Péntek M
Eur J Health Econ; 2019 Jun; 20(Suppl 1):141-154. PubMed ID: 31102159
[TBL] [Abstract][Full Text] [Related]
23. General population reference values for 3-level EQ-5D (EQ-5D-3L) questionnaire in Poland.
Golicki D; Niewada M
Pol Arch Med Wewn; 2015; 125(1-2):18-26. PubMed ID: 25578383
[TBL] [Abstract][Full Text] [Related]
24. EQ-5D-3L as a health measure of Brazilian adult population.
Menezes Rde M; Andrade MV; Noronha KV; Kind P
Qual Life Res; 2015 Nov; 24(11):2761-76. PubMed ID: 25896666
[TBL] [Abstract][Full Text] [Related]
25. EQ-5D-3L derived population norms for health related quality of life in Sri Lanka.
Kularatna S; Whitty JA; Johnson NW; Jayasinghe R; Scuffham PA
PLoS One; 2014; 9(11):e108434. PubMed ID: 25365171
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.
Couzner L; Crotty M; Norman R; Ratcliffe J
Appl Health Econ Health Policy; 2013 Aug; 11(4):415-25. PubMed ID: 23807538
[TBL] [Abstract][Full Text] [Related]
27. EQ-5D-3L health status and health state utilities of the oldest-old (85 +) in Germany: results from the AgeCoDe-AgeQualiDe study.
König HH; Brettschneider C; Lühmann D; Kaduszkiewicz H; Oey A; Wiese B; Werle J; Weyerer S; Fuchs A; Pentzek M; Conrad I; Röhr S; Weeg D; Bickel H; Heser K; Wagner M; Scherer M; Maier W; Riedel-Heller SG; Hajek A
Qual Life Res; 2020 Dec; 29(12):3223-3232. PubMed ID: 32851600
[TBL] [Abstract][Full Text] [Related]
28. Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register.
Teni FS; Rolfson O; Berg J; Leidl R; Burström K
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575317
[No Abstract] [Full Text] [Related]
29. Health-related quality of life within agriculture in England and Wales: results from a EQ-5D-3L self-report questionnaire.
Wheeler R; Lobley M
BMC Public Health; 2022 Jul; 22(1):1395. PubMed ID: 35858865
[TBL] [Abstract][Full Text] [Related]
30. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
31. Population-level norm values by EQ-5D-3L in Hungary - a comparison of survey results from 2022 with those from 2000.
Inotai A; Nagy D; Kaló Z; Vokó Z
Qual Life Res; 2024 Jun; ():. PubMed ID: 38839684
[TBL] [Abstract][Full Text] [Related]
32. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
[TBL] [Abstract][Full Text] [Related]
33. Could the EQ-5D-3L predict all-cause mortality in older Chinese? Evidence from a 5-year longitudinal study in eastern China.
Pan CW; Liu RJ; Yang XJ; Ma QH; Xu Y; Luo N; Wang P
Qual Life Res; 2021 Oct; 30(10):2887-2894. PubMed ID: 34028640
[TBL] [Abstract][Full Text] [Related]
34. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
Willems LM; Knake S; Rosenow F; Reese JP; Conradi N; Strzelczyk A
Epilepsy Behav; 2022 Feb; 127():108554. PubMed ID: 35063789
[TBL] [Abstract][Full Text] [Related]
35. EQ-5D Brazilian population norms.
Santos M; Monteiro AL; Santos B
Health Qual Life Outcomes; 2021 Jun; 19(1):162. PubMed ID: 34112207
[TBL] [Abstract][Full Text] [Related]
36. [Assessment of health-related quality of life in psoriasis patients in Hungary].
Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
[TBL] [Abstract][Full Text] [Related]
37. Predictors of problems reported on the EQ-5D-3L dimensions among people with impaired vision in northern Portugal.
Macedo AF; Hellström A; Massof R; Tuvesson H; Rask M; Ramos PL; Safipour J; Marteinsdottir I; Nilsson E; Fagerström C; Årestedt K
Health Qual Life Outcomes; 2022 Sep; 20(1):132. PubMed ID: 36068600
[TBL] [Abstract][Full Text] [Related]
38. Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries.
Janssen MF; Szende A; Cabases J; Ramos-Goñi JM; Vilagut G; König HH
Eur J Health Econ; 2019 Mar; 20(2):205-216. PubMed ID: 29445941
[TBL] [Abstract][Full Text] [Related]
39. Estimating an exchange rate between the EQ-5D-3L and ASCOT.
Stevens K; Brazier J; Rowen D
Eur J Health Econ; 2018 Jun; 19(5):653-661. PubMed ID: 28623464
[TBL] [Abstract][Full Text] [Related]
40. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
